Articles

UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round | Business Wire

Actia group

Maison France confort

$ IDERA

Adaptimmune to Report Second Quarter 2018 Financial Results and Business Update on Thursday August 2, 2018

mise a jour

Chinese Sorafenib (Bayer) Market Report, 2018-2022 - ResearchAndMarkets.com | Business Wire

Neuralstem Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

BOURSE DE PARIS

PRE-MARKET

CHAMPION DU MONDE